Quantification of Lumefantrine in Human Plasma Using LC-MSMS and Its Application to a Bioequivalence Study

Abstract EN

An analytical method based on protein precipitation has been developed and validated for analysis of lumefantrine in human plasma.

Artesunate was used as an internal standard for lumefantrine.

Inertsil ODS column provided chromatographic separation of analytes followed by detection with mass spectrometry.

The method involves simple isocratic chromatographic condition and mass spectrometric detection in the positive ionization mode using an API-3000 system.

The total run time was 2.5 minutes.

The proposed method has been validated with linear range of 200–20000 ng/mL for lumefantrine.

The intrarun and interrun precision values are within 6.66% and 5.56%, respectively, for lumefantrine at the lower limit of quantification level.

The overall recovery for lumefantrine and artesunate was 93.16% and 91.05%, respectively.

This validated method was used successfully for analysis of plasma samples from a bioequivalence study.